Literature DB >> 12786767

Blink-related microtrauma: when the ocular surface harms itself.

Ivan Cher1.   

Abstract

Superior limbic keratoconjunctivitis results mechanically from blinking under prolonged unphysiological conditions. The pathogenic process is known as blink-related microtrauma. This review aimed to explore the validity of a general theory that besides superior limbic keratoconjunctivitis, there may be other diseases of the ocular surface arising from mechanical microtrauma. A review of relevant clinical and microscopic lesions in a range of ocular surface disorders with possible mechanical aetiology was conducted. New terms were selected to facilitate understanding of such new aetiology. Besides superior limbic keratoconjunctivitis, other ocular surface disorders regarded as primarily derived from blink microtrauma are: other filamentary keratitides; blepharospasm and severe ptosis; canthal/palpebral froth; affections from disordered eyelid lining; and contact lens related damage. A group of secondarily microtraumatic disorders was identified, including the example of microtrauma impacting upon interpalpebral bulbar prominences. Superior limbic keratoconjunctivitis is the archetype of diseases affecting a unique combination; namely, the ocular surface conjoined with its lacrimal fluid. It is only one among many diseases actively generated within the confines of 'a self-harming surface'.

Entities:  

Mesh:

Year:  2003        PMID: 12786767     DOI: 10.1046/j.1442-9071.2003.00633.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  17 in total

Review 1.  [Blinking activity during visual display terminal work. 2: reduced blinking and therapeutic approaches].

Authors:  F Ziemssen; N Freudenthaler; K Regnery; T Schlote
Journal:  Ophthalmologe       Date:  2005-09       Impact factor: 1.059

Review 2.  Graft failure: II. Ocular surface complications.

Authors:  Samar A Al-Swailem
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

3.  Effect of lacrimal plugs combined with deproteinized calf blood extract eye gel for filamentary keratitis.

Authors:  Huibin Lv; Ziyuan Liu; Xuemin Li; Wei Wang
Journal:  J Ocul Biol Dis Infor       Date:  2011-12-17

4.  Comparison of two measurements for the lower lid margin thickness: vernier micrometer and anterior segment optical coherence tomography.

Authors:  Da-Hu Wang; Jie Yao; Xin-Quan Liu
Journal:  Int Ophthalmol       Date:  2020-07-12       Impact factor: 2.031

5.  Superior Limbic Keratoconjunctivitis-like Inflammation in Patients with Chronic Graft-Versus-Host Disease.

Authors:  Kavitha R Sivaraman; Renu V Jivrajka; Ketki Soin; Charles S Bouchard; Asadolah Movahedan; Ellen Shorter; Sandeep Jain; Deborah S Jacobs; Ali R Djalilian
Journal:  Ocul Surf       Date:  2016-05-12       Impact factor: 5.033

Review 6.  [Blinking activity during visual display terminal work. Part 1: Ocular discomfort and pathophysiological principles].

Authors:  F Ziemssen; N Freudenthaler; K Regnery; T Schlote
Journal:  Ophthalmologe       Date:  2005-08       Impact factor: 1.059

7.  Comprehensive approach to ocular consequences of Stevens Johnson Syndrome - the aftermath of a systemic condition.

Authors:  Geetha Iyer; Bhaskar Srinivasan; Shweta Agarwal; Seema Kamala Muralidharan; Sumathi Arumugam
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-01-29       Impact factor: 3.117

8.  Update on limbal stem cell transplantation.

Authors:  Pejman Bakhtiari; Ali Djalilian
Journal:  Middle East Afr J Ophthalmol       Date:  2010-01

Review 9.  Impact of Attrition, Intercellular Shear in Dry Eye Disease: When Cells are Challenged and Neurons are Triggered.

Authors:  Gysbert-Botho van Setten
Journal:  Int J Mol Sci       Date:  2020-06-18       Impact factor: 5.923

10.  Morselized Amniotic Membrane Tissue for Refractory Corneal Epithelial Defects in Cicatricial Ocular Surface Diseases.

Authors:  Anny M S Cheng; Lorraine Chua; Victoria Casas; Scheffer C G Tseng
Journal:  Transl Vis Sci Technol       Date:  2016-05-18       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.